William Rawlinson is a clinician scientist recognised internationally for translational research into human CMV in pregnancy and other immune compromised clinical states. He established, and oversees, serology and virology clinical research programs, statewide transplant donor screening, and national quality programs for serology and biosecurity. The laboratory he directs studies pathogenesis of congenital CMV infection, clinical application of research findings to pregnant women and neonates, and novel antivirals. He is conjoint professor at UNSW with over 400 publications in basic research, diagnostic and clinical virology.